Loading…
Adial Pharmaceuticals, Inc. is projected to rise to $3.89 by 2027, a +7% move from its current price of $3.64. ADIL is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $3.50 | $3.64 | $3.78 | -0.03% |
| Aug 6 | $3.45 | $3.64 | $3.84 | -0.07% |
| Aug 7 | $3.41 | $3.64 | $3.88 | -0.10% |
| Aug 8 | $3.37 | $3.64 | $3.92 | -0.14% |
| Aug 9 | $3.34 | $3.63 | $3.95 | -0.17% |
| Aug 10 | $3.31 | $3.63 | $3.98 | -0.20% |
| Aug 11 | $3.29 | $3.63 | $4.01 | -0.24% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.29 | $3.63 | $4.01 | -0.24% |
| Week 2 | $3.15 | $3.62 | $4.17 | -0.48% |
| Week 3 | $3.04 | $3.61 | $4.30 | -0.71% |
| Week 4 | $2.95 | $3.61 | $4.40 | -0.95% |
| Week 5 | $2.88 | $3.60 | $4.50 | -1.18% |
| Week 6 | $2.81 | $3.59 | $4.58 | -1.42% |
| Week 7 | $2.75 | $3.58 | $4.66 | -1.66% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Adial Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder.
The company was founded in 2010 and is based in Glen Allen, Virginia.
Adial Pharmaceuticals, Inc. (ADIL) is currently priced at $3.29. Its market cap is $7.2M and it ranks 4896. The stock carries a mixed near-term setup but the multi-year forecast suggests a rising average price path and improving upside potential over time.
The forecast shows average prices progressing over the years, with 2026 avg at $3.29 and 2030 avg at $5.15, climbing to $19.26 by 2050 and a max of $41.11 in 2050. The implied returns (ROI) grow across the horizon, reaching 485.5 for the 2050 forecast, while sentiment shifts toward bullish in later years.
A major floor 62.6% below — a decisive break under it would weaken the trend.
The nearest floor, 31.9% below — buyers have tended to step in here.
Resistance now sits 8.2% below — it may act as fresh support.
A major ceiling 7.5% above — clearing it would confirm fresh momentum.
Key ADIL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ADIL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.11 | Buy | $3.15 | Buy |
| MA 10 | $2.92 | Buy | $3.01 | Buy |
| MA 20 | $2.86 | Buy | $2.88 | Buy |
| MA 50 | $2.64 | Buy | $2.65 | Buy |
| MA 100 | $2.15 | Buy | $2.87 | Buy |
| MA 200 | $4.15 | Sell | $4.88 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 73.22 | Sell |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 230.90 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | 22.79 | Buy |
| Bollinger %B (20,2) | 1.14 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.55 | Buy |
| Awesome (5,34) | 0.32 | Buy |
| Ultimate (7,14,28) | 85.51 | Sell |
| Momentum (10) | 0.54 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 3.34 | Buy |
| ADX (14) | 20.73 | Buy |
| ATR (14) | 0.09 | Info |
The 30-day technical picture is neutral overall. RSI14 is 70, and the sentiment remains NEUTRAL.
Near-term levels show a price at $3.29 with a resistance of $3.29 and a support at $2.48. The moving averages place the price above the SMA50 of $2.62 and below the SMA200 of $4.18, highlighting a balance between momentum and longer-term resistance.
The 30-day range runs from $2.55 to $4.25, providing a defined corridor for near-term trading action.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.36 | $3.64 | $4.54 | 0% | Neutral | |
| $3.00 | $3.89 | $5.41 | +7% | Neutral | |
| $2.79 | $3.78 | $5.51 | +4% | Neutral | |
| $3.66 | $5.12 | $7.76 | +41% | Bullish | |
| $4.16 | $6.00 | $9.38 | +65% | Bullish | |
| $4.10 | $6.08 | $9.76 | +67% | Bullish | |
| $4.44 | $6.76 | $11.14 | +86% | Bullish | |
| $3.92 | $6.11 | $10.29 | +68% | Bullish | |
| $3.82 | $6.11 | $10.49 | +68% | Bullish | |
| $4.90 | $8.01 | $14.01 | +120% | Bullish | |
| $5.71 | $10.36 | $19.58 | +185% | Bullish | |
| $10.79 | $23.73 | $50.06 | +552% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.36 | $3.64 | $4.45 | +0.00% |
| September 2026 | $3.10 | $3.71 | $4.59 | +1.95% |
| October 2026 | $2.92 | $3.53 | $4.43 | -4.91% |
| November 2026 | $2.80 | $3.41 | $4.33 | -3.44% |
| December 2026 | $2.89 | $3.54 | $4.54 | +3.88% |
Click any year to see its month-by-month ADIL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ADIL price prediction for 2026 points to an average of $3.64 (low $1.36, high $4.54) — a potential gain of 0% on today's $3.64. A consolidation phase looks the most probable path here.
In 2027, ADIL is projected to trade between $3.00 and $5.41, averaging $3.89 — a potential gain of +7% from today's $3.64. That is up +7% on the projected 2026 average. Price action looks broadly range-bound.
Adial Pharmaceuticals, Inc.'s 2028 outlook centres on $3.78, within a $2.79 to $5.51 range. That is -3% versus the projected 2027 average. That marks a +4% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, ADIL could reach as high as $7.76, with a base case around $5.12 and support toward $3.66 — roughly +41% from $3.64. Momentum favours further upside here.
Expect ADIL to range from $4.16 to $9.38 through 2030. The $6.00 average target implies a +65% move from current prices. That is up +17% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The ADIL price prediction for 2031 points to an average of $6.08 (low $4.10, high $9.76) — a potential gain of +67% on today's $3.64. Momentum favours further upside here.
In 2032, ADIL is projected to trade between $4.44 and $11.14, averaging $6.76 — a potential gain of +86% from today's $3.64. That is up +11% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Adial Pharmaceuticals, Inc.'s 2033 outlook centres on $6.11, within a $3.92 to $10.29 range. That is -10% versus the projected 2032 average. That marks a +68% change versus current levels. Momentum favours further upside here.
By 2034, ADIL could reach as high as $10.49, with a base case around $6.11 and support toward $3.82 — roughly +68% from $3.64. Buyers look set to stay in control over this stretch.
Expect ADIL to range from $4.90 to $14.01 through 2035. The $8.01 average target implies a +120% move from current prices. That is up +31% on the projected 2034 average. Momentum favours further upside here.
The ADIL price prediction for 2040 points to an average of $10.36 (low $5.71, high $19.58) — a potential gain of +185% on today's $3.64. Buyers look set to stay in control over this stretch.
In 2050, ADIL is projected to trade between $10.79 and $50.06, averaging $23.73 — a potential gain of +552% from today's $3.64. That is up +129% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ADIL today (≈ 274.725275 ADIL) could be worth
$6,519.68
+$5,519.68 (+552%) by 2050 · US Dollar
Based on the average projected ADIL price of $23.73 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ADILwould be worth at today's price.
$1,000 invested in ADIL on Jul 31, 2025 (≈ 90.909091 ADIL) would be worth
$330.91
-$669.09 (-66.9%) today · 0.33× · US Dollar
Based on a ADIL entry price of $11 vs. today's $3.64.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.78 | $1,309.35 | +30.9% |
| 1 month ago | $2.81 | $1,295.37 | +29.5% |
| 3 months ago | $1.55 | $2,348.39 | +134.8% |
| 6 months ago | $5.25 | $693.33 | -30.7% |
| 1 year ago | $11 | $330.91 | -66.9% |
| All time (5.0y) ago | $1,631.25 | $2.23 | -99.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ADIL forecast.
Our base-case forecast reaches $7.30 around 2035.
Implied market cap at $7.30: $15.98M
The multi-year forecast points to a higher average price over time, starting from $3.29 in 2026 and rising to $5.15 in 2030, with continued upside to $19.26 by 2050.
From 2029 onward, the forecast carries a bullish sentiment as the average prices and ROIs climb: 2029 avg $4.41, ROI 34.1; 2030 avg $5.15, ROI 56.6; 2031 avg $5.22, ROI 58.5; 2032 avg $5.78, ROI 75.7; 2035 avg $6.66, ROI 102.4; 2040 avg $8.49, ROI 158.1; 2050 avg $19.26, ROI 485.5.
Max values along the horizon show substantial upside potential: 2030 max $8.11; 2035 max $11.75; 2040 max $16.20; 2050 max $41.11.
These are estimates and not guarantees; as with all forecasts, actual results depend on multiple factors and market conditions.
Tap a question to reveal the answer.
Avg price $5.15, Min $3.55, Max $8.11; ROI 56.6; sentiment BULLISH.
Forecasts show a bullish trajectory from 2029 onward, with avg rising to $5.15 by 2030 and $19.26 by 2050, and ROI reaching 485.5 by 2050.
Yes, the max forecast for 2035 is $11.75, with 2032 max $9.59 and 2033 max $8.69; therefore a price above $10 is possible by 2035.
RSI14 is 70 and sentiment is NEUTRAL. The 30-day range is $2.55–$4.25, with support at $2.48 and resistance at $3.29. SMA50 is $2.62 and SMA200 is $4.18.
Current price is $3.29 and market cap is $7.2M; the asset ranks 4896.
Adial Pharmaceuticals, Inc. Community Discussion
0Share your Adial Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.